Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-08 Sale |
2024-08-12 8:33 pm |
Tempest Therapeutics Inc. | TPST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner |
787,999 | $1.2272 | $967,033 | 3,507,056 (Indirect Direct) |
View |
| 2024-07-03 Purchase |
2024-07-08 4:15 pm |
Tempest Therapeutics Inc. | TPST | Brady Stephen R President and CEO |
35,000 | $2.11 | $73,850 | 46,376 (Direct) |
View |
| 2024-07-02 Purchase |
2024-07-03 7:35 pm |
Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer |
4,672 | $2.13 | $9,951 | 9,573 (Direct) |
View |
| 2024-06-28 Purchase |
2024-07-02 4:15 pm |
Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller |
7,500 | $2.16 | $16,200 | 22,168 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-06 5:00 pm |
N/A 2035-01-01 |
Tempest Therapeutics Inc. | TPST | Brady Stephen R President and CEO |
550,000 | $0 | 550,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:00 pm |
N/A 2035-01-01 |
Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer |
270,000 | $0 | 270,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:00 pm |
N/A 2035-01-01 |
Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller |
30,000 | $0 | 30,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:00 pm |
N/A 2035-01-01 |
Tempest Therapeutics Inc. | TPST | Maestas Nicholas Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 6:05 pm |
N/A 2034-06-12 |
Tempest Therapeutics Inc. | TPST | Pellizzari Christine A Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 6:05 pm |
N/A 2034-06-12 |
Tempest Therapeutics Inc. | TPST | NICHOL GEOFFREY Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 6:05 pm |
N/A 2034-06-12 |
Tempest Therapeutics Inc. | TPST | Simantov Ronit Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 6:05 pm |
N/A 2034-06-12 |
Tempest Therapeutics Inc. | TPST | RAAB MICHAEL Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 4:41 pm |
N/A 2034-01-02 |
Tempest Therapeutics Inc. | TPST | Brady Stephen R President and CEO |
250,000 | $0 | 250,000 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 4:40 pm |
N/A 2034-01-02 |
Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 4:39 pm |
N/A 2034-01-02 |
Tempest Therapeutics Inc. | TPST | Trojanowski Justin Principal Accounting Officer |
26,500 | $0 | 26,500 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 4:38 pm |
N/A 2034-01-02 |
Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-10-11 Option Award |
2023-10-13 4:41 pm |
N/A 2033-10-10 |
Tempest Therapeutics Inc. | TPST | Brady Stephen R President and CEO |
725,000 | $0 | 725,000 (Direct) |
View |
| 2023-10-11 Option Award |
2023-10-13 4:39 pm |
N/A 2033-10-10 |
Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-10-11 Option Award |
2023-10-13 4:39 pm |
N/A 2033-10-10 |
Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer |
325,000 | $0 | 325,000 (Direct) |
View |
| 2023-10-11 Option Award |
2023-10-13 4:38 pm |
N/A 2033-10-10 |
Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:53 pm |
N/A 2033-06-14 |
Tempest Therapeutics Inc. | TPST | RAAB MICHAEL Director |
8,200 | $0 | 8,200 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:50 pm |
N/A 2033-06-14 |
Tempest Therapeutics Inc. | TPST | NICHOL GEOFFREY Director |
8,200 | $0 | 8,200 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:48 pm |
N/A 2033-06-14 |
Tempest Therapeutics Inc. | TPST | Pellizzari Christine A Director |
8,200 | $0 | 8,200 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:46 pm |
N/A 2033-06-14 |
Tempest Therapeutics Inc. | TPST | Simantov Ronit Director |
8,200 | $0 | 8,200 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 8:02 pm |
N/A 2033-01-02 |
Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer |
69,700 | $0 | 69,700 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 8:01 pm |
N/A 2033-01-02 |
Tempest Therapeutics Inc. | TPST | Dubensky Thomas W. President |
102,700 | $0 | 102,700 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 8:00 pm |
N/A 2033-01-02 |
Tempest Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer |
177,300 | $0 | 177,300 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 7:59 pm |
N/A 2033-01-02 |
Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance |
38,425 | $0 | 38,425 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 7:57 pm |
N/A 2033-01-02 |
Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller |
20,300 | $0 | 20,300 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-04 08:01 am |
N/A 2032-10-02 |
Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller |
2,500 | $0 | 2,500 (Direct) |
View |
Ownership |
2022-10-04 08:00 am |
N/A 2032-06-26 |
Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller |
0 | $0 | 15,000 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 4:38 pm |
N/A 2032-06-20 |
Tempest Therapeutics Inc. | TPST | Lorenzo Pierre Corporate Controller |
8,477 | $0 | 8,477 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 4:35 pm |
N/A 2032-06-20 |
Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance |
51,270 | $0 | 51,270 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 4:32 pm |
N/A 2032-06-20 |
Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer |
55,680 | $0 | 55,680 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 4:31 pm |
N/A 2032-06-20 |
Tempest Therapeutics Inc. | TPST | Dubensky Thomas W. President |
87,801 | $0 | 87,801 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 4:29 pm |
N/A 2032-06-20 |
Tempest Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer |
173,533 | $0 | 173,533 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:17 pm |
N/A 2032-06-16 |
Tempest Therapeutics Inc. | TPST | Pellizzari Christine A Director |
3,500 | $0 | 3,500 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:16 pm |
N/A 2032-06-16 |
Tempest Therapeutics Inc. | TPST | NICHOL GEOFFREY Director |
3,500 | $0 | 3,500 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:13 pm |
N/A 2032-06-16 |
Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director |
3,500 | $0 | 3,500 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:11 pm |
N/A 2032-06-16 |
Tempest Therapeutics Inc. | TPST | Simantov Ronit Director |
3,500 | $0 | 3,500 (Direct) |
View |